Industry: Few industries have prompted as much comment, or produced as much excitement, as medical advances in the last few years. We have selected some of the most exciting companies in medical development and we are helping them to raise funds to bring life-changing drugs or technologies to market. The two most exciting of these are: :
- A drug that offers a 30% higher survival rate for pancreatic cancer
- A test and diagnostic platform that improves the success of chemotherapy by 50%
Proposition: Both these businesses are issuing shares now and have announced planned revaluations and/or flotation for the first six months of 2020. With several approvals from the Food and Drug Administration in the US imminent we are hoping to see the businesses list at a substantial multiple of current share price.